ArticleCancers2022

Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.

Stephanie Archer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.